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Physiologic Risk Population: Results of the National Inpatient Sample,
2004-7
John S. Lane, III, MD, Cheryl P. Magno, Andrew R. Barleben, Karen T.
Lane, Ninh T. Nguyen and Roy M. Fujitani, MD, Vascular Surgery, UC
Irvine, Orange, CA, and Orange, CA
Objective: The SAPPHIRE trial established that carotid artery stenting
(CAS) is not inferior to carotid endarterectomy (CEA) for patients at high
surgical risk. TheCREST trial has shownCEAhas a lower stroke rate thanCAS,
at the expense of higher cardiac complications. The objective of this studywas to
evaluate the nationwide performance of CAS and CEA in both high-risk (HR)
and low-physiologic-risk (LR) patients, outside of the clinical trial setting.
Methods:Data from theNational Inpatient Sample (NIS) were pooled
for patients undergoing carotid intervention from 2004-2007. HR was
defined as preexisting cardiac disease (CHF, valvular disease) or COPD.
Stroke, death, myocardial infarction, and complication rates were deter-
mined in both HR and LR populations. Multivariate regression analysis was
performed to determine adjusted odds of stroke and death.
Results: From 2004-2007, CEA was performed in 490,665 patients
(HR, 30.6%) and CAS in 50,283 patients (HR, 31.2%). Unadjusted stroke/
death rates were higher for CAS vs CEA in both HR and LR groups (Table).
Myocardial infarction rates were equivalent in the HR population and
slightly higher for CAS in the LR population. Combined complication rates
were higher after CEA vs CAS, mainly due to pulmonary and renal compli-
cations. Multivariate regression analysis revealed adjusted odds of stroke/
death were increased for CAS (OR, 1.36; CI, 1.28-1.45). HR patients had
an equivalent odds of stroke/death after CAS (OR, 1.10; CI, 0.99-1.28),
whereas LR patients had an increased odds (OR, 1.56; CI, 1.45-1.67).
Conclusions: This nationwide, real-world study supports the use of
CAS in the HR population undergoing carotid intervention. However, the
LR population is at higher risk of stroke and death after CAS compared with
CEA. Contrary to the CREST results, both carotid procedures can be
performed with equivalent cardiac morbidity.
EEGMonitoring with SSEPObviates Need for Shunting in CEA, even
with Stroke
Anna Weiss, MD, Anjali Scholten, MD, Jeffrey H. Gertsch, Katherine E.
Brown, MD, and Niren Angle, MD, Surgery, UC San Diego, San Diego,
CA, and San Diego, CA
Objective: The utilization of selective cerebral shunting during carotid
endarterectomy (CEA) has been predicated on surrogate measures such as
contralateral carotid occlusion, back-pressure measurements, and the patient’s
motor and cognitive function with regional anesthesia or recent stroke. This
study analyzed the need for shunting in CEA where comprehensive electroen-
cephalography (EEG) monitoring with somatosensory evoked potentials
(SSEP) was the sole determinant of the necessity of a shunt.
Design: A retrospective review was performed in a single institution of
all consecutive CEAs performed between September 2002 andMarch 2010.
The decision for carotid shunting was based only on changes in continuous
EEG dynamics reflecting ischemia as assessed intraoperatively by a neurolo-
gist. SSEP were used in a portion of cases as a functional confirmation of
EEG findings. No other factor influenced the need for a shunt. Patient
demographics, including age, degree of internal carotid artery (ICA) steno-
Table. Chi-square analysis of carotid interventions
Outcome, % (No.)
High risk (165,741)
CEA
(150,053)
CAS
(15,688)
Stroke/death 4.60 (6908) 6.14 (964)
Stroke/death/MI 7.84 (11,765) 8.99 (1,410)
Complications
MI 3.61 (5416) 3.45 (541)
Pulmonary 3.02 (4529) 1.01 (158)
Renal 0.73 (1092) 0.41 (65)
Combined 6.56 (9838) 4.52 (709) .sis, preoperative neurologic symptoms, and medications were reviewed.
Thirty-day outcomes, including stroke, TIA, death, and other major com-
plications were tabulated.
Results: A total of 163 patients (100 [62.5%] men; mean age 69.4
years, [range, 44-91]) underwent 169 carotid endarterectomies. Of the total
arteries treated, 76 (45%) were symptomatic, of which 66 (39%) had a
documented stroke. A total of 20 patients (11.8%) had high-grade contralat-
eral (80%-99%) ICA stenosis and 12 (7%) had contralateral ICA occlusion.
Only two shunts (1.2%) were used. The 30-day stroke, TIA, death rates were
four (2.3%), zero (0%), and two (1.2%), respectively. There was one intra-
operative stroke and the other three strokes occurred30 days. None of the
patients with contralateral occlusion or contralateral high-grade ICA steno-
sis had EEG changes necessitating a shunt.
Conclusion: Continuous EEG monitoring with SSEP dramatically
reduces the need to place a shunt during CEA. Recent stroke, contralateral
ICA occlusion, or contralateral high-grade ICA stenosis are not an indica-
tion for intraoperative shunting. Shunting for CEA should be vanishingly
rare. EEGwith SSEP should be considered the gold standard for monitoring
of cerebral perfusion during CEA.
Spatial Distribution of Microemboli Following Carotid Interventions
Wei Zhou, MD, Angela R. Laird, PhD, Simon B. Eickhoff, Mickle Fox,
Garrett Chan, Barton Lane, MD, Ronald Dalman, MD, and Allyson Rosen,
PhD, Surgery, StanfordUniversity, Stanford, CA, San Antonio, TX, Aachen,
Germany, Palo Alto, CA, and Stanford, CA
Background: Despite the absence of clinically evident neurologic
symptoms, subclinical microemboli during carotid interventions are com-
mon. Characterizing the typical locations of these lesions is an important
step in identifying neural systems vulnerable to disruption. The purpose of
this study was to examine the distribution of microemboli after carotid
interventions using a novel imaging analysis program.
Methods: Patients who received both preoperative and postoperative
MRI evaluations for carotid interventions at a single academic institution
from 2002 to 2008 were retrospectively evaluated. Microemboli were
defined by new hyperintensities on postoperative diffusion-weighted MRI
sequence (DWI) with corresponding decreased diffusion on the ADC map.
Microemboli regions of interest (ROI) were manually defined (MRICron)
and normalized using SPM5 along with ADC images. ROIs were smoothed
using a conservative Gaussian distribution (FWHM  6 mm) with FSL and
input to a modified version of the Anatomic Likelihood Analysis (ALE)
algorithm, in which a voxel-wise statistic was computed to derive a measure
of agreement across images.
Results: Inter-rater reliability was first established between a board-
certified neuroradiologist with experience detecting microemboli and a
novice rater trained to adequate inter-rater reliability with respect to micro-
embolus volume (R2  0.99) and spatial overlap (similarity index  0.80).
Among 160 patients who underwent carotid interventions and received
both preoperative and postoperative MRI studies, 81 had new postoperative
DWI lesions. Areas with a high degree of convergence across ROIs included
the anterior and posterior cingulate, middle frontal gyrus, insula, basal
ganglia, and occipital areas (Brodmann areas 18 and 19; Fig).
Conclusion: Regions vulnerable to microemboli include those impli-
cated in executive control and motor planning/speeded responses (anterior
P
Low risk (375,207)
P
CEA
(340,612) CAS(34,595)
001 3.61 (12,286) 5.91 (2.044) .001
001 5.52 (18,797) 8.27 (2861) .001
312 2.06 (7.012) 2.66 (921) .001
001 1.04 (3540) 0.39 (136) .001
001 0.72 (2437) 0.16 (54) .001.
.
.
.
.001 3.56 (12,121) 3.12 (1081) .001
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August 2010524 Abstractscingulate, middle frontal gyrus, basal ganglia) and memory (posterior cin-
gulate). This finding forms a basis of selecting an appropriate set neuropsy-
chologic battery to accurately evaluate cognitive effects of microemboli.
Disclosure:The content was partially presented as a poster in Human
Brain Imaging 2009.
Contemporary Management of Aberrant Right Subclavian Arteries
William M. Stone, MD, Joseph J. Ricotta, II, MD, Richard J. Fowl, MD,
Thomas C. Bower,MD, and Samuel R.Money,MD,Dept of Surgery,Mayo
Clinic Arizona, Scottsdale, AZ, Rochester, MN, and Scottsdale, AZ
Background:Aberrant origin of right subclavian arteries represents the
most common of the aortic arch anomalies. This variant has few published
series to guide management. Our goal was to review treatment options and
results for these potentially complex reconstructions.
Methods:A retrospective reviewwas performed on all patients with the
diagnosis of aberrant right subclavian artery at our institution from January
2003 through July 2009.
Results: Nineteen patients, comprising one of the largest series re-
ported, including 9 males and 10 females (mean age, 40.6 years; range,
7-77), were diagnosed with an aberrant right subclavian artery. The diag-
nosis was incidental in 14 (74%), but 5 (26%) had symptoms of dysphagia or
upper extremity ischemia, or both. The diagnosis was established by com-
puted tomography in 15 patients (79%), by magnetic resonance imaging in
3 (15%), and by standard angiography in 1 (5%). The most common
associated anomaly was a Kommerell’s diverticulum (KD), which was found
in five patients (26%), all of whom required intervention for symptoms or
aneurysmal degeneration. Intervention was performed in 10 patients (53%),
including carotid subclavian bypass in 5 (50%), carotid subclavian transpo-
sition in 3 (30%), and ascending aorta to subclavian bypass in 2 (20%). Four
patients (40%) had additional intervention for management of aneurysmal
disease of the aorta or KD, with open aortic replacement in two (20%) and
aortic endografting in two (20%). There was one perioperative death (10%)
in a patient undergoing aortic arch debranching with placement of an aortic
endograft. Eighteen patients were alive without symptoms after a mean
follow-up of 38 months.
Conclusions: Aberrant right subclavian arteries are most commonly
found incidentally with computed tomography. The presence of a KD
appeared to correlate with the need for intervention. Patients with no
symptoms with the absence of a KD can safely be followed.
Fig. Regions vulnerable to microemboli
Table. Patency, limb salvage, and survival rates
1 Mon (%) 3 Mon (%) 6
Primary 89.5 79.6
Primary assisted 91.5 82.2
Secondary 94.9 90.0
Limb salvage 96.3 92.7
Survival 96.7 89.9 86.1Clinical Outcomes and Implications of Failed Infrainguinal Endovas-
cular Stents
Ilia Gur, MD, William Lee, Fred A. Weaver, MD, Vincent L. Rowe, MD,
Gabriel Akopian, and Steven G. Katz, MD, Vascular Surgery, USC, Pasa-
dena, CA, Pasadena, CA, and Los Angeles, CA
Objective: Although the influence of initial TASC II classification has
been clearly shown to influence the primary patency of infrainguinal stenting
procedures, its effect on outcomes once stent failure has occurred is less well
documented. It is the objective of this paper to determine whether clinical
outcomes and implications of anatomic stent failure vary according to initial
TASC II classification
Methods:Results were analyzed by TASC II classification. Kaplan-
Meier survival curves were plotted, and differences between groups tested by
log-rank method. A Cox proportional hazards regression model was used to
perform the multivariate analysis
Results: During a 5-year period, 239 angioplasties and stents were
performed in 192 patients. Primary patency was lost in 69 stented arteries.
Failure was due to one or more hemodynamically significant stenoses in 43
patients and occlusion in 26. After primary stenting, limbs initially classified
as TASC C and D were more likely to fail with occlusion (P  .0001),
require open operation (P  .032), or lose runoff vessels (P  .0034) than
those classified as TASCA or B. In two patients initially classified as TASCC,
stent failure changed the level of the open operation to a more distal site.
Percutaneous reintervention was performed on 35 limbs. Successful reinterven-
tion improved the patency of TASC A and B lesions to 92%, 85%, and 64% and
TASC C and D lesions to 78%, 72%, and 50% at 12, 24, and 36 months,
respectively. Initial TASC classification was highly predictive of first anatomic
failure (P  .0001) but did not predict the durability of subsequent catheter
based reintervention (P .32). Ten patients with stent failure required opera-
tion, and five underwent amputation; all had failed with occlusion. Overall limb
salvage was 89% and periprocedural mortality was 0.4%.
Conclusions: After primary stenting of the SFA and popliteal artery,
lesions classified as TASC C or D are more likely to fail with occlusion, lose
runoff vessels, and alter the site of subsequent open operation than their
TASC A and B counterparts. Although these complications are infrequent,
they may negatively impact later attempts at revascularization and this must
be considered when deciding on the proper treatment strategy for patients
with infrainguinal occlusive disease.
Intraoperative Thrombolysis and Laser Atherectomy: Effective Treat-
ment for TASC C and D Lesions in Critical Limb Ischemia
Sam S. Ahn, MD, Kenneth R. Kollmeyer, MD, Foster A. Hays, Julia F.
Chen, Craig A. Ferrara, MD, Pablo V. Uceda, MD, and Robert W. Feldt-
man, MD, DFW Vascular Group, Dallas, TX, and Dallas, TX
Objective: We postulate that catheter-directed intraoperative throm-
bolysis in conjunction with laser atherectomy is a safe and effective treatment
of TASC C and D critical limb ischemia.
Methods: We retrospectively analyzed 411 patients who underwent
670 percutaneous, lower extremity interventions from September 2004 to
October 2009. Indications for intervention were limb salvage (98.7%) and
claudication (1.3%). TASC C lesions were present in 40.9% of patients and
TASC D lesions in 59.1%. Gender was 51.0% male and 49.0% female.
Average age was 69.5  12.0 years (range, 30-97 years). Risk factors
included hypertension (87.8%), diabetes (70.2%), coronary artery disease
(56.4%), tobacco abuse (54.8%), hyperlipidemia (49.4%), COPD (36.6%),
congestive heart failure (26.3%), renal insufficiency (23.7%), history of
myocardial infarction (21.3%), history of TIA or CVA (20.0%), atrial fibril-
lation (16.6%), dialysis (16.0%), morbid obesity (14.9%), arrhythmia (7.3%),
and pacemaker (6.1%). All procedures involved catheter-directed arterial
infusion of 2 to 10 mg of tissue plasminogen activator into the lesion and
laser atherectomy: 647 extremities required balloon angioplasty, and 326
extremities required stenting. Technical success required completion of the
intended procedure. Clinical success required no deaths, strokes, myocardial
infarctions, bleeding requiring transfusion, thromboemboli, infection, respi-
ratory complications, or reinterventions within 30 days. Follow-up was at 24
hours, 30 days, 6 months, and then every 6 months. Kaplan-Meier analysis
was used for patency, limb salvage, and survival rates.
%) 12 Mon (%) 24 Mon (%) 48 Mon (%)
50.4 43.3 26.5
59.3 51.7 35.8
82.6 78.0 71.2
86.7 81.3 74.5Mon (
66.4
71.0
84.3
88.778.6 69.9 62.4
